HOME >> MEDICINE >> NEWS
Montreal researchers make a major strategic breakthrough in controling the AIDS virus

A team of researchers from the Universit de Montral and the Centre hospitalier de l'Universit de Montral (CHUM) have announced an important breakthrough in fighting the human immunodeficiency virus (HIV). For the first time, scientists have identified a defect in the immune response to HIV and found a way to correct the flaw. Dr. Rafick-Pierre Skaly, an eminent researcher in cell biology, immunology, and virology, has confirmed the identification of a new therapeutic target (the PD-1 protein) that restores the function of the T cells whose role is to eliminate cells infected with the virus. This constitutes a major breakthrough, opening new prospects for the development of therapeutic strategies for controlling HIV infection. The research findings appear in today's issue of the journal Nature Medicine.

Dr. Skaly explained that "immune system cells made non-functional by HIV can be identified by the presence of a protein that is significantly overexpressed when infected by the virus." In fact, high levels of the protein are associated with a more serious dysfunction. "The most important discovery made in this study arises from the fact that by stimulating this protein, we succeeded in preventing the virus from making immune system cells dysfunctional," he added.

The findings were simultaneously reproduced by two other laboratories the labs headed by Dr. Bruce Walker at Harvard and Dr. Richard Koup at the NIH. "It's a rare occurrence for three teams to work together on attacking a major problem. Up until now, the virus has been more or less invincible. By combining our efforts, we found the missing link that may enable us to defeat the virus," noted Dr. Skaly. Discussions with partners are also underway to translate these research findings into clinical trials, which could start during the coming year.

Thanks to the joint efforts of the Universit de Montral, the CHUM Research Centre, Gnome Qubec, Genome Canada, the Canadian Institu
'"/>

Contact: Sophie Langlois
sophie.langlois@umontreal.ca
514-343-7704
University of Montreal
21-Aug-2006


Page: 1 2

Related medicine news :

1. Montreal researchers identify defects of immune cells
2. As Montreal Conference considers deforestation issues, ESA presents space solution
3. ESA participating in UNs Montreal summit working for a better atmosphere
4. Stanford researchers find culprit in aging muscles that heal poorly
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Penn researchers discover novel pathway for increasing good cholesterol
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. UIC researchers to develop new drugs to fight bioterrorism
9. UQ researchers discover some of the oldest forms of life
10. U of M researchers discover new method to combat HIV
11. U of M researchers assess effectiveness of computerized physician order entry system

Post Your Comments:
(Date:5/20/2013)... May 20, 2013 Co-founder of ... be a keynote speaker at the 5th International INVEST ... The conference brings together company representatives and independent individuals ... in Internet marketing and investments. , The 2013 conference ... Business Hotel México from May 20 to 21. A ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 The ... business and community leaders behind bars for good at ... May 22 beginning at 9 a.m. , More ... annual Executive Lock-Up to benefit individuals and families affected ... present, including city officials, local celebrities, realtors, doctors, attorneys, ...
(Date:5/20/2013)... May 20, 2013 ... Who:    Sloan Gibson, President, USO and CEO ... of Outreach Initiatives and Partners, Sesame ... , Representatives from:,              ... • U.S. House ...
(Date:5/20/2013)... York (PRWEB) May 20, 2013 National law ... P.A. and Thrash Law Firm P.A., both based in Little ... approval of the proposed $7.25 billion settlement of a price-fixing ... fees. The objection was filed Wednesday, May 15, 2013, in ... York. The related lawsuit against Visa and MasterCard (Case No. ...
(Date:5/20/2013)... York, New York (PRWEB) May 20, 2013 ... a new study has found that magnetic resonance imaging (MRI) ... failure, regardless of whether or not patients are experiencing symptoms. ... the Journal of Bone & Joint Surgery, MRI detected ... In patients suffering symptoms due to mechanical causes, the ...
Breaking Medicine News(10 mins):Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4
(Date:5/20/2013)... 2013  Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical ... unique technology to deter prescription drug abuse today ... Anthony Soscia , has been chosen as ... ,s Health-Care Heroes Awards. The awards are presented ... to honor individuals and organizations demonstrating excellence and deserving ...
(Date:5/20/2013)... , May 20, 2013 Enrollment of patients ... Phase 2b dose-finding clinical trial of product candidate ... foundational treatment for Type 2 diabetes. Elcelyx expects to ... program in June. Results of the trial,s primary endpoint ... late summer, and the read-out for long-term glucose lowering ...
(Date:5/20/2013)... , May 20, 2013  Neuralstem, Inc. (NYSE MKT: ... , MD, PhD, principal investigator, presented updated Phase I ... (NSI-566) trial in the treatment of amyotrophic lateral sclerosis ... at the neuro diabetes special medical symposium in ... talk called "Recent Therapeutic Advances in Stem Cell Therapy," ...
Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: